Anavex Life Sciences Corp (AVXL)

[Steady_T]

The simplest answer is that to use your statistics the trail would need to run for at least 4 years.

The present trials are scheduled to be considerably shorter than that. Also Anavex is selecting trial subjects a that are in the earlier stages of AD.

Then there is the issue with your statistic as shown below.

Life expectancy varies for each person with AD. The average life expectancy after diagnosis is eight to 10 years. In some cases, however, it can be as short as three years or as long as 20 years.
Life Expectancy and Long-Term Outlook for Alzheimer's Disease
https://www.healthline.com › health › alzheimers-disease › life-expectancy

https://www.ncbi.nlm.nih.gov › pubmed
by R Brookmeyer - ?2002 - ?Cited by 340 - ?Related articles
Survival following a diagnosis of Alzheimer disease. ... The median survival times ranged from 8.3 years for persons diagnosed as having AD at age 65 years to 3.4 years for persons diagnosed as having AD at age 90 years.